Features

 
Ocular Surgery News (OSN) Europe (9/25/18)
Pravin Dugel, MD: Risuteganib Complements Anti-VEGF Treatment for Diabetic Macular Edema

EyeWorld (Video) (9/24/18)
Pravin Dugel, MD: Luminate as an anti-integrin intravitreal injection for DME

Healio.com/Ocular Surgery News (Video) (8/6/18)
Peter K. Kaiser, MD: Luminate blocks integrin receptors, reduces oxidative stress

MedPage Today (7/26/18)
Charles Bankhead, Senior Associate Editor: New Drugs Show Promise in Retinopathy

EyeTube (Video) (7/23/18)
Vicken Karageozian, MD: Update on the company’s lead investigational drug, Luminate (risuteganib), for the treatment of diabetic macular edema (DME) as the company prepares to enter phase 3 clinical trials.

Healio.com/Ocular Surgery News (Video) (7/21/18)
Vicken Karageozian, MD: Luminate shows neuroprotective effect

Healio.com/Ocular Surgery News (Video) (7/5/18)
Vicken Karageozian, MD: Allegro preps to move into phase 3 trial with DME treatment

Modern Retina (6/5/18)
David S. Boyer, MD: The role of oxidative stress in DME